LLY

Eli Lilly and Company · FWB:LLY

1,268.80 EUR40.20 +3.27%

Eli Lilly and Company (FWB:LLY) last traded at 1,268.80 EUR, up 3.27% on the day. Over the past year the stock is up 81.80%. Its 52-week range is 728.90 to 1,287.20. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open1,239.20

Day range1,239.20 – 1,287.20

52-week range728.90 – 1,287.20

Volume285

Average volume (10 days)232

Market cap (USD)1.33 T

P/E47.22

EPS (TTM) (USD)30.44

Dividend yield0.47%

Beta (1 year)0.3795

Revenue (TTM) (USD)86.46 B

Employees50.00 K

Performance

+9.55%1 week

+21.00%1 month

+26.68%3 months

+72.77%6 months

+37.82%Year to date

+81.80%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

1,306.65 EUR

The average 1-year price target, +2.98% from the last price. See the forecast

Latest headlines

Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.